{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"P1M","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","metadata_created":"2020-02-06T20:11:10.098831","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-02-06T20:11:10.098840","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-02-06","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Santé publique","réseaux","synthèse des connaissances","application des connaissances","équité en santé","déterminants de la santé","pratique éclairée par des données probantes","prise de décisions éclairées par des données probantes"],"en":["Public health","networks","knowledge synthesis","knowledge translation","health equity","determinants of health","evidence-informed practice","evidence-informed decision-making"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 46–2/3 - fév/mars 2020 : Réseau de santé publique","en":"CCDR: Volume 46–2/3 -  Feb/Mar 2020: Public Health Network "},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"101c47f2-e1fb-4c3f-8df6-16b72ab21e1e","related_relationship":"","name_translated":{"fr":"RMTC : Vol. 46 No. 2/3-fév/mars 2020 : Réseau de santé publique","en":"CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network","language":["en"],"created":"2020-02-06T20:11:12.092549","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020.html","last_modified":null,"position":0,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"48e7ef75-491d-4591-b7bd-6dc35b3e53ba","related_relationship":"","name_translated":{"fr":"RMTC : Vol. 46 No. 2/3-fév/mars 2020 : Réseau de santé publique","en":"CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network","language":["fr"],"created":"2020-02-06T20:11:12.092558","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020.html","last_modified":null,"position":1,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"id":"2ed23318-1cc9-4d63-9ac2-1b982f3bca29","character_set":"","state":"active","name_translated":{"fr":"RMTC : Vol. 46 No. 2/3-fév/mars 2020 : Réseau de santé publique","en":"CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network","language":["en"],"created":"2020-02-06T20:11:12.092561","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23-eng.pdf","last_modified":null,"position":2,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b20b26b3-c4ec-4cef-b67a-4b1f92d304e8","related_relationship":"","name_translated":{"fr":"RMTC : Vol. 46 No. 2/3-fév/mars 2020 : Réseau de santé publique","en":"CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network","language":["fr"],"created":"2020-02-06T20:11:12.092563","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23f-fra.pdf","last_modified":null,"position":3,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1ef747a9-6825-4906-a739-d5e5673ae18a","related_relationship":"","name_translated":{"fr":"Le réseautage : Une activité de santé publique par excellence","en":"Networking—A quintessential public health activity"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Networking—A quintessential public health activity","language":["en"],"created":"2020-02-06T20:11:12.092566","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-1-networking-public-health.html","last_modified":null,"position":4,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0810b719-3366-4c03-b170-53c287b3923f","related_relationship":"","name_translated":{"fr":"Le réseautage : Une activité de santé publique par excellence","en":"Networking—A quintessential public health activity"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Networking—A quintessential public health activity","language":["fr"],"created":"2020-02-06T20:11:12.092568","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-1-reseautage-sante-publique.html","last_modified":null,"position":5,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"227c2788-1022-4538-98db-47f3a72465ec","related_relationship":"","name_translated":{"fr":"Le réseautage : Une activité de santé publique par excellence","en":"Networking—A quintessential public health activity"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Networking—A quintessential public health activity","language":["fr"],"created":"2020-02-06T20:11:12.092571","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a01f-fra.pdf","last_modified":null,"position":6,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9ff855f5-91a5-4b44-a037-22088b676cc2","related_relationship":"","name_translated":{"fr":"Le réseautage : Une activité de santé publique par excellence","en":"Networking—A quintessential public health activity"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Networking—A quintessential public health activity","language":["en"],"created":"2020-02-06T20:11:12.092573","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a01-eng.pdf","last_modified":null,"position":7,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"843a33fb-9004-4912-9bc2-25186dc3bcfb","related_relationship":"","name_translated":{"fr":"Les Centres de collaboration nationale du Canada : Faciliter la prise de décisions informées par des données probantes en santé publique","en":"Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health","language":["en"],"created":"2020-02-06T20:11:12.092576","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-2-canada-national-collaboration-centres-public-health.html","last_modified":null,"position":8,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"42476d17-2845-4194-a015-b70070c98ea1","related_relationship":"","name_translated":{"fr":"Les Centres de collaboration nationale du Canada : Faciliter la prise de décisions informées par des données probantes en santé publique","en":"Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health","language":["fr"],"created":"2020-02-06T20:11:12.092594","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-2-centre-collaboration-nationale-sante-publique-canada.html","last_modified":null,"position":9,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5be16118-2ba9-43ab-8375-5ed54f09d99a","related_relationship":"","name_translated":{"fr":"Les Centres de collaboration nationale du Canada : Faciliter la prise de décisions informées par des données probantes en santé publique","en":"Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health","language":["en"],"created":"2020-02-06T20:11:12.092596","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a02-eng.pdf","last_modified":null,"position":10,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cbb5a8a3-a6d4-4fbd-af74-5e217e097095","related_relationship":"","name_translated":{"fr":"Les Centres de collaboration nationale du Canada : Faciliter la prise de décisions informées par des données probantes en santé publique","en":"Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health","language":["fr"],"created":"2020-02-06T20:11:12.092598","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a02f-fra.pdf","last_modified":null,"position":11,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3a1ebeda-b99b-48d0-b43e-e1490f3027b7","related_relationship":"","name_translated":{"fr":"Résumé de la déclaration du CCNI sur l’utilisation du vaccin bivalent dirigé contre la protéine de liaison au facteur H (MenB-fHBP) pour la prévention de l’infection à méningocoque du sérogroupe B","en":"Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease","language":["en"],"created":"2020-02-06T20:11:12.092600","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-3-naci-bivalent-factor-h-binding-protein-meningococcal-serogroup-b.html","last_modified":null,"position":12,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7660b87b-ff9a-4fe3-ad27-cbabb04683d7","related_relationship":"","name_translated":{"fr":"Résumé de la déclaration du CCNI sur l’utilisation du vaccin bivalent dirigé contre la protéine de liaison au facteur H (MenB-fHBP) pour la prévention de l’infection à méningocoque du sérogroupe B","en":"Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease","language":["fr"],"created":"2020-02-06T20:11:12.092603","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-3-ccni-proteine-liaison-bivalente-facteur-h-meningocoque-serogroupe-b.html","last_modified":null,"position":13,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0c10b6d5-92a9-4b0d-ae59-b0ee5f777c4e","related_relationship":"","name_translated":{"fr":"Résumé de la déclaration du CCNI sur l’utilisation du vaccin bivalent dirigé contre la protéine de liaison au facteur H (MenB-fHBP) pour la prévention de l’infection à méningocoque du sérogroupe B","en":"Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease","language":["en"],"created":"2020-02-06T20:11:12.092605","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a03-eng.pdf","last_modified":null,"position":14,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"552bcac7-6c9b-49d9-9205-1d687a2b7d87","related_relationship":"","name_translated":{"fr":"Résumé de la déclaration du CCNI sur l’utilisation du vaccin bivalent dirigé contre la protéine de liaison au facteur H (MenB-fHBP) pour la prévention de l’infection à méningocoque du sérogroupe B","en":"Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease","language":["fr"],"created":"2020-02-06T20:11:12.092607","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a03f-fra.pdf","last_modified":null,"position":15,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7c0d9fd6-e3c4-47f2-ac9e-416e76217962","related_relationship":"","name_translated":{"fr":"Bris de retraitement des dispositifs médicaux dans une clinique de médecine familiale d’Ottawa, en Ontario, en 2018","en":"Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018","language":["en"],"created":"2020-02-06T20:11:12.092610","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-4-infection-prevention-control-lapse-ontario-2018.html","last_modified":null,"position":16,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f4ad80bb-4a5b-49b2-b806-235ac5f46a08","related_relationship":"","name_translated":{"fr":"Bris de retraitement des dispositifs médicaux dans une clinique de médecine familiale d’Ottawa, en Ontario, en 2018","en":"Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018","language":["fr"],"created":"2020-02-06T20:11:12.092612","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-4-prevention-infections-manquements-mesures-controle-ontario-2018.html","last_modified":null,"position":17,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"93badbf9-dc27-468d-8e75-cbc89e620344","related_relationship":"","name_translated":{"fr":"Bris de retraitement des dispositifs médicaux dans une clinique de médecine familiale d’Ottawa, en Ontario, en 2018","en":"Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018","language":["en"],"created":"2020-02-06T20:11:12.092614","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a04-eng.pdf","last_modified":null,"position":18,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d14b7dcd-80c3-4343-af04-027d36d0b1c8","related_relationship":"","name_translated":{"fr":"Bris de retraitement des dispositifs médicaux dans une clinique de médecine familiale d’Ottawa, en Ontario, en 2018","en":"Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018","language":["fr"],"created":"2020-02-06T20:11:12.092616","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a04f-fra.pdf","last_modified":null,"position":19,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a88426c4-7e39-436d-82f9-015792ffc85b","related_relationship":"","name_translated":{"fr":"Optimisation du matériel de communication pour vaincre l’hésitation à la vaccination","en":"Optimizing communication material to address vaccine hesitancy"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Optimizing communication material to address vaccine hesitancy","language":["en"],"created":"2020-02-06T20:11:12.092619","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-5-best-practices-addressing-vaccine-hesitancy.html","last_modified":null,"position":20,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ddee1f61-4c1c-45f7-987f-e516e49e028c","related_relationship":"","name_translated":{"fr":"Optimisation du matériel de communication pour vaincre l’hésitation à la vaccination","en":"Optimizing communication material to address vaccine hesitancy"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Optimizing communication material to address vaccine hesitancy","language":["fr"],"created":"2020-02-06T20:11:12.092637","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-5-pratiques-exemplaires-face-reticence-vaccination.html","last_modified":null,"position":21,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2eb36706-f5fc-4ee2-8f9d-7da3b2c60c55","related_relationship":"","name_translated":{"fr":"Optimisation du matériel de communication pour vaincre l’hésitation à la vaccination","en":"Optimizing communication material to address vaccine hesitancy"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Optimizing communication material to address vaccine hesitancy","language":["en"],"created":"2020-02-06T20:11:12.092639","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a05-eng.pdf","last_modified":null,"position":22,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"924c719e-0394-41fc-9b7f-a9595e82681b","related_relationship":"","name_translated":{"fr":"Optimisation du matériel de communication pour vaincre l’hésitation à la vaccination","en":"Optimizing communication material to address vaccine hesitancy"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Optimizing communication material to address vaccine hesitancy","language":["fr"],"created":"2020-02-06T20:11:12.092641","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a05f-fra.pdf","last_modified":null,"position":23,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9bdc3cc5-64f0-4c19-954f-32928e5cdc54","related_relationship":"","name_translated":{"fr":"Des partenariats efficaces pour répondre aux priorités de santé publique; L’impact des partenariats médico-légaux pour améliorer les résultats de santé; Nouveau coronavirus de 2019 : Mise à jour sur l’éclosion","en":"Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update","language":["en"],"created":"2020-02-06T20:11:12.092643","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-6-id-news.html","last_modified":null,"position":24,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1a587e8a-a184-4c6f-b68a-8bfcce38ed91","related_relationship":"","name_translated":{"fr":"Des partenariats efficaces pour répondre aux priorités de santé publique; L’impact des partenariats médico-légaux pour améliorer les résultats de santé; Nouveau coronavirus de 2019 : Mise à jour sur l’éclosion","en":"Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update","language":["fr"],"created":"2020-02-06T20:11:12.092646","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-6-actualites-maladies-infectieuses.html","last_modified":null,"position":25,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"63ec164d-e1c4-40fe-bb36-510e6ec4e0a5","related_relationship":"","name_translated":{"fr":"Des partenariats efficaces pour répondre aux priorités de santé publique; L’impact des partenariats médico-légaux pour améliorer les résultats de santé; Nouveau coronavirus de 2019 : Mise à jour sur l’éclosion","en":"Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update","language":["en"],"created":"2020-02-06T20:11:12.092648","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a06-eng.pdf","last_modified":null,"position":26,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cc986d1f-fab7-4c7a-967c-41c400eb2e01","related_relationship":"","name_translated":{"fr":"Des partenariats efficaces pour répondre aux priorités de santé publique; L’impact des partenariats médico-légaux pour améliorer les résultats de santé; Nouveau coronavirus de 2019 : Mise à jour sur l’éclosion","en":"Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update","language":["fr"],"created":"2020-02-06T20:11:12.092650","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a06f-fra.pdf","last_modified":null,"position":27,"revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f","resource_type":"website"}],"place_of_publication":[],"num_resources":28,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2020-02-06 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"3bc27326-51f3-489e-aa0f-aa3166b37ed1","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 46–2/3 -  Feb/Mar 2020: Public Health Network ","revision_id":"37269f8e-c846-488e-8a27-1cbba3541a9f"}